CarthroniX

Lancaster, United States

CarthroniX is a pharmaceutical company that offers small molecule based therapy, wound healing, skin regeneration, and novel solutions.

$2.3M raised

Apr 2022

Convertible Note

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has CarthroniX raised?

CarthroniX has raised $2.3M in total funding. The most recent round was Convertible Note. The last funding was announced in April 2022.

Who are CarthroniX's investors?

CarthroniX's investors include Pacira Pharmaceuticals.

Where is CarthroniX headquartered?

CarthroniX is headquartered in Lancaster, United States.

What does CarthroniX do?

CarthroniX is a pharmaceutical company that offers small molecule based therapy, wound healing, skin regeneration, and novel solutions.

What stage is CarthroniX at?

CarthroniX is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 11, 2022.

MLA

"CarthroniX — Funding & Investors." VCBacked, April 11, 2022, https://www.vcbacked.co/company/carthronix. Accessed July 2, 2026.

APA

VCBacked. (2022). CarthroniX — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/carthronix

Wikipedia (cite web)

{{cite web |title=CarthroniX — Funding & Investors |url=https://www.vcbacked.co/company/carthronix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 11, 2022.